Introduction
Over the years, China has also established a viable genomic institute; and the government continues to invest colossal sums of money to develop authentic technologies and build competent molecular sciences workforce. Recently, the high-speed large capacity disk array system was installed in of the nation’s genomic institutes. This computational machine was developed to handle copious amounts of data and maintain the capacity to save such data. Besides the data backup capability, their new computer has the capacity to protect sensitive research data from unexpected loss. The intrinsic goal of the Chinese human genome center has been to contribute to human society through the development of efficient diagnosis of illnesses, prevention and the application of effective therapeutic interventions to meet the needs of the society.
The Beijing Genomic Institute (BGI) is one of China’s leading research facilities on throughput sequencing-based profiling tools, and the institute is committed to excellence in genome sciences. BGI continues to conduct a large-scale genomic research in bioinformatics, genome dynamics, and genotyping with over 100 bioinformatics specialists. Research scientists at BGI have focused their investigations on the Human HapMap project, the super-hybrid Rice Genome project, silkworm genome, chicken genome variation in collaboration with United Kingdom and United States partners and the Sino-Danish pig genome project.
Other technologically savvy developing nations such as Brazil, Korea, and India have directed their research interest on their pharmaceutical industry; systematically using genomic science and bioinformatics to develop agriculture, chemicals, biodefense, and energy. Brazil now leads the world in biofuels and the prevention of citrus diseases. Korea continues to invest in cloning and tissue engineering. As these technological initiatives occur at exponential rate in the developed nations, we continue to observe imminent setbacks in developing and underdeveloped nations.